These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 1516063

  • 21. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968
    [Abstract] [Full Text] [Related]

  • 22. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
    Khokhar AR, al-Baker S, Shamsuddin S, Siddik ZH.
    J Med Chem; 1997 Jan 03; 40(1):112-6. PubMed ID: 9016335
    [Abstract] [Full Text] [Related]

  • 23. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
    Ramos-Lima FJ, Quiroga AG, García-Serrelde B, Blanco F, Carnero A, Navarro-Ranninger C.
    J Med Chem; 2007 May 03; 50(9):2194-9. PubMed ID: 17407274
    [Abstract] [Full Text] [Related]

  • 24. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line.
    Mauldin SK, Husain I, Sancar A, Chaney SG.
    Cancer Res; 1986 Jun 03; 46(6):2876-82. PubMed ID: 3698013
    [Abstract] [Full Text] [Related]

  • 25. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR.
    Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660
    [Abstract] [Full Text] [Related]

  • 26. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR.
    Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261
    [Abstract] [Full Text] [Related]

  • 27. Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes.
    Wheate NJ, Webster LK, Brodie CR, Collins JG.
    Anticancer Drug Des; 2000 Oct 15; 15(5):313-22. PubMed ID: 11354307
    [Abstract] [Full Text] [Related]

  • 28. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N, Natile G, Capitelli F, Fanizzi FP, Boccarelli A, De Rinaldis P, Giordano D, Coluccia M.
    J Inorg Biochem; 2006 Nov 15; 100(11):1849-57. PubMed ID: 16959321
    [Abstract] [Full Text] [Related]

  • 29. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
    Zorbas-Seifried S, Jakupec MA, Kukushkin NV, Groessl M, Hartinger CG, Semenova O, Zorbas H, Kukushkin VY, Keppler BK.
    Mol Pharmacol; 2007 Jan 15; 71(1):357-65. PubMed ID: 17050805
    [Abstract] [Full Text] [Related]

  • 30. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U, Sabat M, Farrell N.
    Inorg Chem; 2000 May 01; 39(9):1882-90. PubMed ID: 11428108
    [Abstract] [Full Text] [Related]

  • 31. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 32. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
    Bekhit AA, El-Sayed OA, Al-Allaf TA, Aboul-Enein HY, Kunhi M, Pulicat SM, Al-Hussain K, Al-Khodairy F, Arif J.
    Eur J Med Chem; 2004 Jun 15; 39(6):499-505. PubMed ID: 15183908
    [Abstract] [Full Text] [Related]

  • 33. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P, Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P, Speroni GP.
    Anticancer Drug Des; 1998 Jan 15; 13(1):67-80. PubMed ID: 9474243
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.
    Halámiková A, Heringová P, Kaspárková J, Intini FP, Natile G, Nemirovski A, Gibson D, Brabec V.
    J Inorg Biochem; 2008 Jan 15; 102(5-6):1077-89. PubMed ID: 18237783
    [Abstract] [Full Text] [Related]

  • 35. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides.
    Zhao G, Lin H, Zhu S, Sun H, Chen Y.
    Anticancer Drug Des; 1998 Oct 15; 13(7):769-77. PubMed ID: 9807161
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
    Boccarelli A, Intini FP, Sasanelli R, Sivo MF, Coluccia M, Natile G.
    J Med Chem; 2006 Jan 26; 49(2):829-37. PubMed ID: 16420068
    [Abstract] [Full Text] [Related]

  • 37. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
    Boccarelli A, Coluccia M, Intini FP, Natile G, Locker D, Leng M.
    Anticancer Drug Des; 1999 Jun 26; 14(3):253-64. PubMed ID: 10500500
    [Abstract] [Full Text] [Related]

  • 38. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 26; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 39. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA, Salas JM, Romero MA, Vilaplana R, Gonzalez-Vílchez F, Faure R.
    J Med Chem; 1998 Jan 29; 41(3):332-8. PubMed ID: 9464364
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
    Farrell N, Povirk LF, Dange Y, DeMasters G, Gupta MS, Kohlhagen G, Khan QA, Pommier Y, Gewirtz DA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):857-66. PubMed ID: 15294448
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.